Cargando…

Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats

This study aimed to investigate the antiproteinuric and hyperkalemic mechanisms activated by dual renin-angiotensin system (RAS) blockade in renovascular hypertensive rats (2-kidney 1-clip model [2K-1C]). Six weeks after clipping the left renal artery or sham operation (2K), rats were treated with l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corrêa, José Wilson N., Boaro, Karoline R., Sene, Letícia B., Polidoro, Juliano Z., Salles, Thiago A., Martins, Flavia L., Bendhack, Lusiane M., Girardi, Adriana C. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221266/ https://www.ncbi.nlm.nih.gov/pubmed/34177612 http://dx.doi.org/10.3389/fphys.2021.656460

Ejemplares similares

Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study
por: Boesby, Lene, et al.
Publicado: (2011)

Is the Antiproteinuric Effect of Cyclosporine A Independent of Its Immunosuppressive Function in T Cells?
por: Zhang, Bin, et al.
Publicado: (2012)

Hyperkalemic paralysis in primary adrenal insufficiency
por: Mishra, Ajay, et al.
Publicado: (2014)

Hyperkalemic Arrest: Developing Team Cognition
por: Giordano, Chris, et al.
Publicado: (2017)

Hyperkalemic Paralysis Due to Addison’s Disease
por: Chiwome, Lawman, et al.
Publicado: (2021)

Contribution of oxidative stress to endothelial dysfunction in hypertension
por: Silva, Bruno R., et al.
Publicado: (2012)

Evaluation of antiproteinuric and hepato-renal protective activities of propolis in paracetamol toxicity in rats
por: El Menyiy, Nawal, et al.
Publicado: (2018)

Hyperkalemic periodic paralysis with paramyotonia and the anaesthetic implications
por: Sender, David, et al.
Publicado: (2023)

Effect of systemic arterial hypertension and use of antiproteinuric drug in induction therapy for lupus nephritis
por: Matta, Eduardo Grecco, et al.
Publicado: (2020)

Reversible electrophysiological abnormalities in acute secondary hyperkalemic paralysis
por: Naik, Karkal R., et al.
Publicado: (2012)

Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?
por: Dobson, Geoffrey P., et al.
Publicado: (2013)

Hyperkalemic Cardiac Arrest in a Patient with Diabetic Ketoacidosis
por: Manappallil, Robin G, et al.
Publicado: (2020)

Patiromer and maintenance of RAASi therapy in hyperkalemic medicare patients
por: Desai, Nihar R., et al.
Publicado: (2019)

Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy
por: Warnock, David G, et al.
Publicado: (2015)

Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR
por: Trimarchi, H., et al.
Publicado: (2014)

Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes
por: Advani, Andrew, et al.
Publicado: (2013)

Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease
por: Capelli, Irene, et al.
Publicado: (2023)

Transfusion-Associated Hyperkalemic Cardiac Arrest in Neonatal, Infant, and Pediatric Patients
por: Burke, Morgan, et al.
Publicado: (2021)

Renovascular hypertension in children
por: Patel, Premal Amrishkumar, et al.
Publicado: (2021)

Characterization of hyperkalemic periodic paralysis: a survey of genetically diagnosed individuals
por: Charles, G., et al.
Publicado: (2013)

Hyperkalemic Periodic Paralysis: Case Report with a SCNA4 Gene Mutation and Literature Review
por: Quiroga-Carrillo, Manuela, et al.
Publicado: (2020)

Hipertensión renovascular : presentación caso clínico
por: Barrientos Landa, Emilio
Publicado: (1998)

Exercise training attenuates renovascular hypertension partly via RAS- ROS- glutamate pathway in the hypothalamic paraventricular nucleus
por: Zhang, Yan, et al.
Publicado: (2016)

Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors
por: Kloner, Robert A., et al.
Publicado: (2018)

ECG alterations suggestive of hyperkalemia in normokalemic versus hyperkalemic patients
por: Varga, Csaba, et al.
Publicado: (2019)

The Role of Glycocalyx and Caveolae in Vascular Homeostasis and Diseases
por: Potje, Simone Regina, et al.
Publicado: (2021)

Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease
por: Keber, Tajda, et al.
Publicado: (2017)

Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD
por: Wouda, Rosa D, et al.
Publicado: (2021)

Imaging in the evaluation of renovascular disease
por: Tullus, Kjell, et al.
Publicado: (2009)

Revisiting angioplasty for renovascular hypertension
por: Sag, Alan A., et al.
Publicado: (2017)

Inhibition of phosphodiesterase 5 restores endothelial function in renovascular hypertension
por: Dias, Ananda T, et al.
Publicado: (2014)

Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension
por: Dias, Ananda T, et al.
Publicado: (2014)

Hyperkalemic Recurrent Bilateral Lower Extremity Weakness in a Patient on Hemodialysis
por: Hassen, Getaw Worku, et al.
Publicado: (2012)

Familial Hyperkalemic Hypertension: A New Early-onset Pediatric Case
por: Pela, Ivana
Publicado: (2012)

Acute hyperkalemia leading to flaccid paralysis: a review of hyperkalemic manifestations
por: Karmacharya, Paras, et al.
Publicado: (2015)

Anti-arrhythmic effects of hypercalcemia in hyperkalemic, Langendorff-perfused mouse hearts
por: Tse, Gary, et al.
Publicado: (2016)

The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension
por: Hureaux, Marguerite, et al.
Publicado: (2021)

Anesthetic Management in Familial Hyperkalemic Periodic Paralysis: A Case Report
por: Atoot, Ali, et al.
Publicado: (2021)

A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Failure
por: Ghamry, Mohamed A, et al.
Publicado: (2022)

Ruthenium Complexes as NO Donors for Vascular Relaxation Induction
por: Galvão de Lima, Renata, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jp8d5ker9fhafrnvrpkkeq49pg